Work with your provider to submit thorough documentation of your BMI, weight-related health conditions, and previous weight loss attempts
First, administration is once weekly, not daily semaglutides long half-life is the whole reason the label uses a weekly cadence
Theyre newer, but sometimes being smaller means a more personal, responsive experience
Phase III, PIONEER Program Multiple phase III efficacy trials have been fully published and/or presented in abstract form
The most robust evidence to date comes from a phase 2 randomised controlled trial (Jastreboff et al., New England Journal of Medicine , 2023), in which retatrutide was evaluated over 48 weeks in adults with obesity but without type 2 diabetes
No Phase 3 MASH trial has been registered in the TRIUMPH programme as of 2026